Anaphylaxis
Publication Date: December 17, 2023
Key Points
Key Points
- Anaphylaxis is an acute, potential life-threatening systemic allergic reaction that may have a wide range of clinical manifestations.
- Severe anaphylaxis and/or the need for repeated doses of epinephrine to treat anaphylaxis are risk factors for biphasic anaphylaxis.
- Antihistamines and/or glucocorticoids are not reliable interventions to prevent biphasic anaphylaxis.
Diagnosis
Diagnosi...
The Joint Task Force suggests that a clinicia...
...Force suggests extended clinical observation in...
Treatment
...eatmen...
...ask Force suggests against administering...
...sk Force suggests in favor of administe...
...Task Force suggests against routin...
...e Joint Task Force suggests in favor...
Good Practice Stat...
...ster epinephrine as the first-line pharmaco...
...lay the administration of epinephrine f...
...diagnosis and treatment of anaphylaxis,...
...patients with anaphylaxis should receive educat...
...Key Clinical Advice...
...ere anaphylaxis and/or the need for >1 dose o...
...llustratio...